Merck’s most recent trend suggests a bullish bias. One trading opportunity on Merck is a Bull Put Spread using a strike $46.00 short put and a strike $41.00 long put offers a potential 5.71% return on risk over the next 37 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $46.00 by expiration. The full premium credit of $0.27 would be kept by the premium seller. The risk of $4.73 would be incurred if the stock dropped below the $41.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Merck is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Merck is bullish.
The RSI indicator is at 60.42 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Merck
German Merck Hikes Its 2013 Profit Projection and 2 Other Dow Movers to Watch
Thu, 14 Nov 2013 18:11:09 GMT
Wall St. Cheat Sheet – These stocks are moving the Dow now.
MERCK & CO. INC. Financials
Thu, 14 Nov 2013 18:04:15 GMT
Here’s Who’s Getting Rich off Obamacare
Thu, 14 Nov 2013 13:25:22 GMT
Watch The R&D Chiefs Of Pfizer, Merck, And Amgen Discuss The Drug Industry’s Challenges
Thu, 14 Nov 2013 12:52:00 GMT
Forbes – Matthew Herper, Mikael Dolsten, Sean Harper & Roger Perlmutter A big moment at the Forbes Healthcare Summit last month: I was on stage with the R&D chief of three of the biggest drug companies on the planet. Roger Perlmutter, formerly of Amgen but now head of research at Merck, talked about […]
German drug maker Merck ups forecast for 2013
Thu, 14 Nov 2013 12:22:54 GMT
Also on Market Tamer…
Follow Us on Facebook